Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Savaria Announces Date for Fourth Quarter 2025 Financial Results
-
GovSignals Achieves DoW IL5 Authorization with Second Front Systems, Bringing Secure Acquisition AI to Defense and Federal Missions
-
Salem Podcast Network Announces Launch of The Danielle Gill Show
-
Grassroots Carbon Joins Colorado State University Consortium to Advance Soil Carbon Modeling at National Scale
-
Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New Flavours
-
A New Era for Men’s Health Begins: AUA Proud to Support Landmark Office of Men’s Health Legislation
-
J-Star Signs Exclusive Distribution Agreement with PSSB
-
Renx Enterprises Provides Corporate Update to Shareholders
-
Abits Group Inc Announces $2.1 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
-
Solana Company (NASDAQ: HSDT) Announces Plan for the Pacific Backbone, a High-Speed Infrastructure Buildout for Solana
-
La Rosa Holdings Announces Voluntary Executive Salary Reductions by 60%
-
DeFi Development Corp. Publishes New Valuation Framework, Sets $10,000 SOL Price Target
-
Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination
-
Flywire Appoints Patrick Blanc as Chief Technology Officer
-
Notified Adds Market Intelligence to IR Hub™ Making Earnings Call Preparation Easier
-
Editas Medicine to Participate in Upcoming Investor Conferences
-
Schouw & Co. share buy-back programme, week 8 2026
-
Custom Ink Launches First Major Brand Refresh in 15 Years
-
Potpie AI raises $2.2 million to make AI agents usable inside real-world engineering systems
-
AIM ImmunoTech Announces Planned Milestones in the Ongoing Phase 2 Trial of Ampligen and AstraZeneca’s Durvalumab in the Treatment of Metastatic Pancreatic Cancer
-
Outlook (guidance) for 2026
-
Blue Star Families and the National Governors Association Launch Do Your Part State Toolkit to Support Military Families
-
Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board
-
Capgemini joins forces with OpenAI to accelerate new era of AI-powered enterprise transformation with Frontier Alliance
-
East Nordeau Zone on Globex Royalty Claims Returns High-Grade Gold Drill Results
-
Donerail Issues Additional Open Letter to MarineMax Shareholders
-
Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026
-
No-code’s backend bottleneck is history
-
Bond Selected by $300B+ Global Pharmaceutical Leader to Protect Employees
-
A.P. Møller - Mærsk A/S – Transactions in connection with share buy-back program
-
PharmAla To Supply Amsterdam UMC with LaNeo™ MDMA, Including Development of New Single-Capsule Stability Data
-
Consolidated Water Declares Second Quarter Cash Dividend
-
Lakeland Fire + Safety Appoints Lee D. Rudow to the Board of Directors
-
Global Water Resources to Attend the 38th Annual ROTH Conference, March 22-24, 2026
-
Edible Garden Reports 2025 Sustainability Performance Through Walmart’s Project Gigaton
-
Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion
-
Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One
-
NetworkNews Audio Announces Audio Press Release (APR) Discussing Growing Investor Attention on Companies Holding Clinical-Stage Portfolios
-
BreachRx Appoints Young-Sae Song as Chief Marketing Officer to Accelerate Shift to Enterprise-Wide, Governed Cyber Incident Response Management
-
Fulton Financial Corporation and Blue Foundry Bancorp Announce Regulatory Approvals and Anticipated Merger Closing Date
-
CISO Global Appoints Dhaval Damania as EVP of Cybersecurity & IT
-
APPLOVIN INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates AppLovin Corporation’s Directors and Officers for Breach of Fiduciary Duties – APP
-
Sutro Biopharma Announces Participation at the 16th World ADC London Summit
-
IP Strategy Launches Treasury Yield-Enhancement Program
-
BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman
-
American Rebel Holdings, Inc. (NASDAQ: AREB) announces a partnership with Jefferson Distributing to launch American Rebel Light Beer in West Virginia’s Eastern Panhandle, expanding distribution acro
-
OptimumBank Holdings, Inc. Announces Formation of OptimumFunding to Launch HUD and FHA Lending Platform
-
Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
-
AI Service Robotics Market Accelerates as Platforms Move from Prototype to Revenue Deployment
-
Ultragenyx Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application (BLA) for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
